Search - tctmd.com

Displaying 21 - 40 of 54

Sort: Relevancy | Date

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Daily News

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

L.A. McKeown

June 29, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Daily News

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Michael O'Riordan

April 29, 2016

News Daily News

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

Todd Neale

March 15, 2016

News Daily News

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

L.A. McKeown

February 03, 2016

News Conference News TCT 2015

Trial Results Often Struggle to Keep Pace With Evolving Technology

Nicole Lou

October 13, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Conference News ACC 2015

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

L.A. McKeown

March 16, 2015

News Daily News

CABG Achieves Better 30-Day Outcomes vs PCI in Younger Patients, Similar 5-year Mortality

Yael L. Maxwell

May 15, 2014

News Daily News

Mortality Varies by Revascularization Method in Dialysis Patients

Caitlin E. Cox

April 19, 2013

Advertisement

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Top News in Coronary Artery Disease: 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

Trial Results Often Struggle to Keep Pace With Evolving Technology

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

CABG Achieves Better 30-Day Outcomes vs PCI in Younger Patients, Similar 5-year Mortality

Mortality Varies by Revascularization Method in Dialysis Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content